Jean-pierre Van Geertruyden
Clinical trials sponsored by Jean-pierre Van Geertruyden, explained in plain language.
-
Mpox vaccine trial for pregnant women launches in congo
⭐️ VACCINE ⭐️ OngoingThis study tests the safety and immune response of the MVA-BN mpox vaccine in 359 pregnant and postpartum women in the Democratic Republic of the Congo. Some women receive the vaccine during pregnancy, others right after giving birth, and a small group gets it as an emergency sho…
Phase: PHASE3 • Sponsor: Jean-Pierre Van geertruyden • Aim: ⭐️ VACCINE ⭐️
Last updated May 17, 2026 11:38 UTC
-
Mpox vaccine trial for babies launches in congo: could half a dose be enough?
⭐️ VACCINE ⭐️ OngoingThis study tests the safety and immune response of the MVA-BN mpox vaccine in 344 infants and children aged 4 to 24 months in the Democratic Republic of the Congo. Half of the children receive a full dose and half receive a half dose, both given as two shots 28 days apart. The go…
Phase: PHASE3 • Sponsor: Jean-Pierre Van geertruyden • Aim: ⭐️ VACCINE ⭐️
Last updated May 11, 2026 20:47 UTC